Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

We need more questions for the certifying exam... put your ideas here... #12

Open
voyagermedical opened this issue Oct 13, 2022 · 8 comments

Comments

@voyagermedical
Copy link
Contributor

We have made a new database of OSPAT certifying questions, there is currently one question in the database we probably need at least 20. Please use this thread to submit any questions you have. For instance...

Which of the following psychedelics has the shortest duration of action?
=DMT
LSD
Psilocybin
Mescaline
Ketamine

Which of the following psychedelics has the quickest onset of action?
=Smoked DMT
Ingested LSD
Ingested Psilocybin
Ingested Mescaline from Bridgesi
Ingested Ketamine

@voyagermedical
Copy link
Contributor Author

Which of the following is a correct statement regarding the effects of LSD on the brain?
Stimulates the activity of dopamine
Inhibits the activity of serotonin
=Stimulates the activity of serotonin
Imitates the activity of glutamate
Imitates the activity of dopamine

How was LSD discovered?
Ancient civilizations have eaten their leaves for thousands of years.
A German scientist was looking for a new stimulant drug.
=A Swiss scientist was looking for a new headache cure.
The CIA was looking for a new truth serum

What is one of the most dangerous aspects to eating psychedelic mushrooms?
They frequently cause heart attacks, even on the first use.
=Poisonous mushrooms can easily be mistaken for them.
They cause extreme overheating and dehydration.
Some people have profound allergies to them that can lead to death.

Where does mescaline come from?
A German scientist looking for a new stimulant drug discovered it.
It is found in the leaves of the mescalinus sativa plant.
=It is found in part of the peyote cactus.
It was developed in the 1920s as an anaesthetic.

Which of the following is true about PCP?
It was developed as a cure for migraine headaches.
It was developed as a truth serum for the CIA.
It was used in the 1950s as a blood pressure medication.
=It was used in the 1950s as a surgical anaesthetic.

In the brain, PCP:
Stimulates the activity of dopamine
Imitates the activity of dopamine
Disrupts the activity of serotonin
Stimulates the activity of glutamate
=Disrupts the activity of glutamate

@unshakenme
Copy link
Owner

unshakenme commented Oct 28, 2022

These are great questions so far, although they all probably fall within the topic of molecules. We definitely need to have a wide range of questions focused on clinical skill and interventions for therapists in addition to these.

@voyagermedical
Copy link
Contributor Author

Something like this?

Behaviour analysis is based upon the principles of:

~Classical conditioning.
=Operant conditioning.
~Dream analysis.
~All of the options.

@unshakenme
Copy link
Owner

Sorry for the delay. Yes that is getting warmer, although I should have been more specific. We need to have questions focused on clinical skill and interventions within the context of psychedelic therapy.

Some examples would be...

What is the best example of the appropriate use of therapeutic touch?

~Whenever the client experiences affect.
=Only in cases agreed upon by the client during preparation sessions.
~When the client is elated or overwhelmed and asking for physical touch.
~All of the above.

How many therapists should participate in sessions according to the MAPS MDMA-Assisted Therapy protocol?
~1
=2
~3
~As many as possible.

@voyagermedical
Copy link
Contributor Author

Would anyone else like to contribute?

@unshakenme
Copy link
Owner

I've been thinking about this lately and am starting to believe we should hold off until there are more contributors. In my mind it makes sense that a dedicated team or committee would take the lead on developing the questions but I don't think we have enough contributors for that yet.

Thoughts?

@CheekeyMonkey
Copy link
Collaborator

Well thats the main problem atmo. There's not enough contributors to this repo...

@unshakenme
Copy link
Owner

I agree.

Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

No branches or pull requests

3 participants